HALO · Halozyme Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Helen Torley PRESIDENT AND CEO | ▼ Sell | Open Market | 767,780 Shares held | 10/8/2026 | View profile |
| Connie Matsui Director | ▼ Sell | Gift | 183,035 Shares held | 11/29/2024 | View profile |
| LaBarre Michael J. SVP, Chief Technical Officer | ▼ Sell | Open Market | 173,756 Shares held | 2/27/2025 | View profile |
| Jean-Pierre Bizzari Director | ▲ Buy | Grant | 66,815 Shares held | 5/5/2023 | View profile |
| Matthew L. Posard Director | ▼ Sell | Open Market | 53,609 Shares held | 10/1/2026 | View profile |
| Mark Howard Snyder SVP, GENERAL COUNSEL | ▼ Sell | Tax Withholding | 49,929 Shares held | 6/12/2026 | View profile |
| Bernadette Connaughton Director | ▼ Sell | Open Market | 40,418 Shares held | 8/10/2026 | View profile |
| Nicole LaBrosse SVP, Chief Financial Officer | ▼ Sell | Tax Withholding | 38,494 Shares held | 2/23/2026 | View profile |
| Jeffrey William Henderson Director | ▲ Buy | Grant | 36,572 Shares held | 5/5/2026 | View profile |
| Miyashita Akiko Moni Director | ▲ Buy | Grant | 24,937 Shares held | 5/1/2025 | View profile |
| Barbara Gayle Duncan | ▲ Buy | Grant | 23,715 Shares held | 5/5/2026 | View profile |
| Masaru Matsuda See Remarks | ▼ Sell | Tax Withholding | 20,049 Shares held | 9/4/2021 | View profile |
| Mahesh Krishnan | ▼ Sell | Open Market | 14,462 Shares held | 6/29/2026 | View profile |
| Cortney Caudill SVP, CHIEF OPERATING OFFICER | ▼ Sell | Open Market | 7,055 Shares held | 3/10/2026 | View profile |
| James Paul Lang Director | ▲ Buy | Grant | 4,685 Shares held | 5/5/2026 | View profile |
| David A. Ramsay Director | ▼ Sell | Tax Withholding | 4,592 Shares held | 6/30/2026 | View profile |
| James M. Daly Director | ▲ Buy | Grant | 1,169 Shares held | 10/1/2026 | View profile |
| Appelhans Dannielle Director | ▲ Buy | Grant | 1,161 Shares held | 9/1/2026 | View profile |
Transaction History
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $368K | 10/8/2026 |
| Helen Torley | ▼ Sell | Open Market | 4,810 | $520K | 10/8/2026 |
| Helen Torley | ▼ Sell | Open Market | 3,090 | $337K | 10/8/2026 |
| Helen Torley | ▼ Sell | Open Market | 11,900 | $1.3M | 10/8/2026 |
| Helen Torley | ▼ Sell | Open Market | 200 | $22K | 10/8/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $368K | 10/7/2026 |
| Helen Torley | ▼ Sell | Open Market | 8,600 | $955K | 10/7/2026 |
| Helen Torley | ▼ Sell | Open Market | 10,300 | $1.2M | 10/7/2026 |
| Helen Torley | ▼ Sell | Open Market | 900 | $102K | 10/7/2026 |
| Helen Torley | ▼ Sell | Open Market | 200 | $23K | 10/7/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $368K | 10/6/2026 |
| Helen Torley | ▼ Sell | Open Market | 2,300 | $248K | 10/6/2026 |
| Helen Torley | ▼ Sell | Open Market | 6,000 | $656K | 10/6/2026 |
| Helen Torley | ▼ Sell | Open Market | 9,920 | $1.1M | 10/6/2026 |
| Helen Torley | ▼ Sell | Open Market | 1,780 | $197K | 10/6/2026 |
| James M. Daly | ▲ Buy | Grant | 1,169 | $0 | 10/1/2026 |
| Matthew L. Posard | ▼ Sell | Open Market | 730 | $78K | 10/1/2026 |
| Matthew L. Posard | ▼ Sell | Open Market | 3,300 | $358K | 10/1/2026 |
| Matthew L. Posard | ▼ Sell | Open Market | 1,100 | $121K | 10/1/2026 |
| Matthew L. Posard | ▼ Sell | Open Market | 100 | $11K | 10/1/2026 |
| Matthew L. Posard | ▼ Sell | Open Market | 3,100 | $329K | 9/16/2026 |
| Matthew L. Posard | ▼ Sell | Open Market | 3,000 | $320K | 9/16/2026 |
| Matthew L. Posard | ▼ Sell | Open Market | 8,896 | $961K | 9/16/2026 |
| Matthew L. Posard | ▼ Sell | Open Market | 4,000 | $436K | 9/16/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $368K | 9/11/2026 |
| Helen Torley | ▼ Sell | Open Market | 15,492 | $1.7M | 9/11/2026 |
| Helen Torley | ▼ Sell | Open Market | 4,508 | $485K | 9/11/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $368K | 9/10/2026 |
| Helen Torley | ▼ Sell | Open Market | 14,588 | $1.6M | 9/10/2026 |
| Helen Torley | ▼ Sell | Open Market | 5,412 | $582K | 9/10/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $368K | 9/9/2026 |
| Helen Torley | ▼ Sell | Open Market | 6,596 | $711K | 9/9/2026 |
| Helen Torley | ▼ Sell | Open Market | 13,304 | $1.4M | 9/9/2026 |
| Helen Torley | ▼ Sell | Open Market | 100 | $11K | 9/9/2026 |
| Appelhans Dannielle | ▲ Buy | Grant | 1,161 | $0 | 9/1/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $368K | 8/19/2026 |
| Helen Torley | ▼ Sell | Open Market | 7,200 | $766K | 8/19/2026 |
| Helen Torley | ▼ Sell | Open Market | 9,600 | $1.0M | 8/19/2026 |
| Helen Torley | ▼ Sell | Open Market | 3,200 | $345K | 8/19/2026 |
| Helen Torley | ▼ Sell | Open Market | 5,703 | $588K | 8/18/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $368K | 8/18/2026 |
| Helen Torley | ▼ Sell | Open Market | 4,897 | $510K | 8/18/2026 |
| Helen Torley | ▼ Sell | Open Market | 9,400 | $986K | 8/18/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $368K | 8/17/2026 |
| Helen Torley | ▼ Sell | Open Market | 900 | $89K | 8/17/2026 |
| Helen Torley | ▼ Sell | Open Market | 500 | $50K | 8/17/2026 |
| Helen Torley | ▼ Sell | Open Market | 2,100 | $214K | 8/17/2026 |
| Helen Torley | ▼ Sell | Open Market | 9,000 | $923K | 8/17/2026 |
| Helen Torley | ▼ Sell | Open Market | 7,500 | $776K | 8/17/2026 |
| Bernadette Connaughton | ▼ Sell | Open Market | 1,626 | $167K | 8/10/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 1,923 | $23K | 7/8/2026 |
| Helen Torley | ▼ Sell | Open Market | 888 | $70K | 7/8/2026 |
| Helen Torley | ▼ Sell | Open Market | 1,035 | $83K | 7/8/2026 |
| Bernadette Connaughton | ▼ Sell | Open Market | 1,000 | $76K | 7/1/2026 |
| Bernadette Connaughton | ▼ Sell | Open Market | 625 | $48K | 7/1/2026 |
| David A. Ramsay | ▲ Buy | Option Exercise | 10,000 | $0 | 6/30/2026 |
| David A. Ramsay | ▼ Sell | Tax Withholding | 5,408 | $423K | 6/30/2026 |
| Mahesh Krishnan | ▲ Buy | Option Exercise | 7,304 | $281K | 6/29/2026 |
| Mahesh Krishnan | ▼ Sell | Open Market | 7,304 | $548K | 6/29/2026 |
| Mark Howard Snyder | ▲ Buy | Option Exercise | 5,034 | $0 | 6/12/2026 |
| Mark Howard Snyder | ▼ Sell | Tax Withholding | 2,715 | $189K | 6/12/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 10,000 | $121K | 6/3/2026 |
| Helen Torley | ▼ Sell | Open Market | 400 | $27K | 6/3/2026 |
| Helen Torley | ▼ Sell | Open Market | 1,500 | $102K | 6/3/2026 |
| Helen Torley | ▼ Sell | Open Market | 2,000 | $137K | 6/3/2026 |
| Helen Torley | ▼ Sell | Open Market | 6,100 | $425K | 6/3/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $241K | 6/2/2026 |
| Helen Torley | ▼ Sell | Open Market | 16,600 | $1.1M | 6/2/2026 |
| Helen Torley | ▼ Sell | Open Market | 3,400 | $227K | 6/2/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $241K | 6/1/2026 |
| Helen Torley | ▼ Sell | Open Market | 1,610 | $107K | 6/1/2026 |
| Helen Torley | ▼ Sell | Open Market | 12,989 | $876K | 6/1/2026 |
| Helen Torley | ▼ Sell | Open Market | 5,401 | $369K | 6/1/2026 |
| Bernadette Connaughton | ▼ Sell | Open Market | 1,625 | $108K | 6/1/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 10,000 | $121K | 5/13/2026 |
| Helen Torley | ▼ Sell | Open Market | 2,100 | $143K | 5/13/2026 |
| Helen Torley | ▼ Sell | Open Market | 3,350 | $231K | 5/13/2026 |
| Helen Torley | ▼ Sell | Open Market | 3,950 | $276K | 5/13/2026 |
| Helen Torley | ▼ Sell | Open Market | 600 | $42K | 5/13/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $241K | 5/12/2026 |
| Helen Torley | ▼ Sell | Open Market | 100 | $7K | 5/12/2026 |
| Helen Torley | ▼ Sell | Open Market | 1,398 | $98K | 5/12/2026 |
| Helen Torley | ▼ Sell | Open Market | 9,802 | $700K | 5/12/2026 |
| Helen Torley | ▼ Sell | Open Market | 5,900 | $426K | 5/12/2026 |
| Helen Torley | ▼ Sell | Open Market | 2,800 | $205K | 5/12/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $241K | 5/11/2026 |
| Helen Torley | ▼ Sell | Open Market | 9,725 | $629K | 5/11/2026 |
| Helen Torley | ▼ Sell | Open Market | 3,575 | $234K | 5/11/2026 |
| Helen Torley | ▼ Sell | Open Market | 6,700 | $444K | 5/11/2026 |
| Mahesh Krishnan | ▲ Buy | Grant | 3,796 | $0 | 5/5/2026 |
| James Paul Lang | ▲ Buy | Grant | 3,796 | $0 | 5/5/2026 |
| Matthew L. Posard | ▲ Buy | Grant | 3,796 | $0 | 5/5/2026 |
| Jeffrey William Henderson | ▲ Buy | Grant | 3,796 | $0 | 5/5/2026 |
| Barbara Gayle Duncan | ▲ Buy | Grant | 3,796 | $0 | 5/5/2026 |
| Bernadette Connaughton | ▲ Buy | Grant | 6,796 | $0 | 5/5/2026 |
| Bernadette Connaughton | ▼ Sell | Open Market | 1,625 | $103K | 5/1/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 10,000 | $121K | 4/6/2026 |
| Helen Torley | ▼ Sell | Open Market | 5,900 | $373K | 4/6/2026 |
| Helen Torley | ▼ Sell | Open Market | 4,100 | $262K | 4/6/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $241K | 4/2/2026 |
| Helen Torley | ▼ Sell | Open Market | 15,800 | $1.0M | 4/2/2026 |
| Helen Torley | ▼ Sell | Open Market | 4,200 | $273K | 4/2/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $241K | 4/1/2026 |
| Helen Torley | ▼ Sell | Open Market | 19,000 | $1.2M | 4/1/2026 |
| Helen Torley | ▼ Sell | Open Market | 1,000 | $66K | 4/1/2026 |
| Cortney Caudill | ▲ Buy | Option Exercise | 1,546 | $52K | 3/10/2026 |
| Cortney Caudill | ▼ Sell | Open Market | 8,857 | $599K | 3/10/2026 |
| Cortney Caudill | ▲ Buy | Option Exercise | 20,000 | $670K | 3/9/2026 |
| Cortney Caudill | ▼ Sell | Open Market | 17,900 | $1.2M | 3/9/2026 |
| Cortney Caudill | ▼ Sell | Open Market | 2,100 | $143K | 3/9/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 10,000 | $121K | 3/4/2026 |
| Helen Torley | ▼ Sell | Open Market | 7,329 | $513K | 3/4/2026 |
| Helen Torley | ▼ Sell | Open Market | 2,671 | $189K | 3/4/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $241K | 3/3/2026 |
| Helen Torley | ▼ Sell | Open Market | 13,481 | $928K | 3/3/2026 |
| Helen Torley | ▼ Sell | Open Market | 6,519 | $452K | 3/3/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $241K | 3/2/2026 |
| Helen Torley | ▼ Sell | Open Market | 4,100 | $284K | 3/2/2026 |
| Helen Torley | ▼ Sell | Open Market | 15,322 | $1.1M | 3/2/2026 |
| Helen Torley | ▼ Sell | Open Market | 578 | $41K | 3/2/2026 |
| Helen Torley | ▼ Sell | Tax Withholding | 12,104 | $855K | 2/23/2026 |
| Mark Howard Snyder | ▲ Buy | Option Exercise | 7,011 | $0 | 2/23/2026 |
| Mark Howard Snyder | ▼ Sell | Tax Withholding | 3,782 | $267K | 2/23/2026 |
| Nicole LaBrosse | ▲ Buy | Option Exercise | 6,688 | $0 | 2/23/2026 |
| Nicole LaBrosse | ▼ Sell | Tax Withholding | 3,608 | $255K | 2/23/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 22,436 | $0 | 2/23/2026 |
| Cortney Caudill | ▲ Buy | Option Exercise | 2,666 | $0 | 2/20/2026 |
| Cortney Caudill | ▼ Sell | Tax Withholding | 1,037 | $74K | 2/20/2026 |
| Mark Howard Snyder | ▲ Buy | Option Exercise | 5,332 | $0 | 2/20/2026 |
| Mark Howard Snyder | ▼ Sell | Tax Withholding | 2,876 | $204K | 2/20/2026 |
| Nicole LaBrosse | ▲ Buy | Option Exercise | 5,332 | $0 | 2/20/2026 |
| Nicole LaBrosse | ▼ Sell | Tax Withholding | 2,876 | $204K | 2/20/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 16,757 | $0 | 2/20/2026 |
| Helen Torley | ▼ Sell | Tax Withholding | 9,040 | $642K | 2/20/2026 |
| Mark Howard Snyder | ▲ Buy | Option Exercise | 4,796 | $0 | 2/16/2026 |
| Mark Howard Snyder | ▼ Sell | Tax Withholding | 2,587 | $206K | 2/16/2026 |
| Mark Howard Snyder | ▲ Buy | Option Exercise | 12,016 | $0 | 2/16/2026 |
| Mark Howard Snyder | ▼ Sell | Tax Withholding | 6,481 | $515K | 2/16/2026 |
| Nicole LaBrosse | ▲ Buy | Option Exercise | 5,093 | $0 | 2/16/2026 |
| Nicole LaBrosse | ▼ Sell | Tax Withholding | 2,747 | $218K | 2/16/2026 |
| Nicole LaBrosse | ▲ Buy | Option Exercise | 5,329 | $0 | 2/16/2026 |
| Nicole LaBrosse | ▼ Sell | Tax Withholding | 2,874 | $228K | 2/16/2026 |
| Nicole LaBrosse | ▲ Buy | Option Exercise | 13,351 | $0 | 2/16/2026 |
| Nicole LaBrosse | ▼ Sell | Tax Withholding | 7,273 | $578K | 2/16/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 21,009 | $0 | 2/16/2026 |
| Helen Torley | ▼ Sell | Tax Withholding | 11,334 | $900K | 2/16/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 16,875 | $0 | 2/16/2026 |
| Helen Torley | ▼ Sell | Tax Withholding | 9,104 | $723K | 2/16/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 51,171 | $0 | 2/16/2026 |
| Helen Torley | ▼ Sell | Tax Withholding | 27,605 | $2.2M | 2/16/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 10,000 | $121K | 2/5/2026 |
| Helen Torley | ▼ Sell | Open Market | 5,376 | $421K | 2/5/2026 |
| Helen Torley | ▼ Sell | Open Market | 4,624 | $365K | 2/5/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $241K | 2/4/2026 |
| Helen Torley | ▼ Sell | Open Market | 9,900 | $762K | 2/4/2026 |
| Helen Torley | ▼ Sell | Open Market | 10,100 | $783K | 2/4/2026 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $241K | 2/3/2026 |
| Helen Torley | ▼ Sell | Open Market | 2,551 | $191K | 2/3/2026 |
| Helen Torley | ▼ Sell | Open Market | 9,659 | $734K | 2/3/2026 |
| Helen Torley | ▼ Sell | Open Market | 7,790 | $598K | 2/3/2026 |
| Bernadette Connaughton | ▼ Sell | Open Market | 2,000 | $141K | 1/5/2026 |
| Mark Howard Snyder | ▲ Buy | Option Exercise | 7,611 | $0 | 1/3/2026 |
| Mark Howard Snyder | ▼ Sell | Tax Withholding | 4,243 | $298K | 1/3/2026 |
| James Paul Lang | ▲ Buy | Grant | 889 | $0 | 1/2/2026 |
| Bernadette Connaughton | ▼ Sell | Open Market | 829 | $59K | 12/1/2025 |
| Helen Torley | ▼ Sell | Open Market | 500 | $35K | 12/1/2025 |
| Helen Torley | ▼ Sell | Open Market | 261 | $19K | 12/1/2025 |
| Helen Torley | ▼ Sell | Open Market | 10,406 | $713K | 12/1/2025 |
| Helen Torley | ▼ Sell | Open Market | 5,402 | $375K | 12/1/2025 |
| Helen Torley | ▲ Buy | Option Exercise | 16,569 | $134K | 12/1/2025 |
| Helen Torley | ▼ Sell | Gift | 25,000 | $0 | 11/26/2025 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $162K | 11/12/2025 |
| Helen Torley | ▼ Sell | Open Market | 12,718 | $893K | 11/12/2025 |
| Helen Torley | ▼ Sell | Open Market | 6,784 | $482K | 11/12/2025 |
| Helen Torley | ▼ Sell | Open Market | 498 | $36K | 11/12/2025 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $162K | 11/11/2025 |
| Helen Torley | ▼ Sell | Open Market | 4,000 | $275K | 11/11/2025 |
| Helen Torley | ▼ Sell | Open Market | 11,500 | $802K | 11/11/2025 |
| Helen Torley | ▼ Sell | Open Market | 4,500 | $306K | 11/11/2025 |
| Helen Torley | ▼ Sell | Open Market | 19,900 | $1.4M | 11/10/2025 |
| Bernadette Connaughton | ▼ Sell | Open Market | 2,000 | $137K | 11/10/2025 |
| Helen Torley | ▼ Sell | Open Market | 100 | $7K | 11/10/2025 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $162K | 11/10/2025 |
| Cortney Caudill | ▲ Buy | Option Exercise | 9,326 | $0 | 11/1/2025 |
| Cortney Caudill | ▼ Sell | Open Market | 4,263 | $278K | 11/1/2025 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $162K | 10/3/2025 |
| Helen Torley | ▼ Sell | Open Market | 14,235 | $975K | 10/3/2025 |
| Helen Torley | ▼ Sell | Open Market | 2,334 | $163K | 10/3/2025 |
| Helen Torley | ▼ Sell | Open Market | 2,707 | $191K | 10/3/2025 |
| Helen Torley | ▼ Sell | Open Market | 724 | $52K | 10/3/2025 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $162K | 10/2/2025 |
| Helen Torley | ▼ Sell | Open Market | 6,600 | $465K | 10/2/2025 |
| Helen Torley | ▼ Sell | Open Market | 10,200 | $727K | 10/2/2025 |
| Helen Torley | ▼ Sell | Open Market | 2,400 | $173K | 10/2/2025 |
| Helen Torley | ▼ Sell | Open Market | 700 | $51K | 10/2/2025 |
| Helen Torley | ▼ Sell | Open Market | 100 | $7K | 10/2/2025 |
| Helen Torley | ▲ Buy | Option Exercise | 20,000 | $162K | 10/1/2025 |
| Helen Torley | ▼ Sell | Open Market | 11,705 | $879K | 10/1/2025 |
| Helen Torley | ▼ Sell | Open Market | 8,295 | $628K | 10/1/2025 |
| Bernadette Connaughton | ▼ Sell | Open Market | 1,500 | $113K | 10/1/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Halozyme Adds Jim Daly to Board Amid Q2 Earnings Review
Halozyme Therapeutics has appointed Jim Daly to its Board of Directors, a move that signals continued focus on governance and long-term strategy. This update arrives alongside a broader market review of the company's Q2 performance relative to other therapeutics firms. The stock is currently trading above its average analyst target price, with recent technical data showing confirmation near key support levels.
Halozyme Adds Jim Daly to Board Amid Q2 Earnings Review. Halozyme Therapeutics has appointed Jim Daly to its Board of Directors, a move that signals continued focus on governance and long-term strategy. This update arrives alongside a broader market review of the company's Q2 performance relative to other therapeutics firms. The stock is currently trading above its average analyst target price, with recent technical data showing confirmation near key support levels.